References
[1] Muncan B. Cardiovascular disease in racial/ethnic minority populations: illness burden and overview of community-based interventions. Public Health Rev [Internet]. 2018;39(1). Available from: http://dx.doi.org/10.1186/s40985-018-0109-4
[2] Cardiovascular disease [Internet]. Nhs.uk. Available from: https://www.nhs.uk/conditions/cardiovascular-disease/. Accessed August 23, 2020.
[3] Cardiovascular diseases (CVDs) [Internet]. Who.int. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed August 23, 2020.
[4] Francis DK, On behalf of the U.S. Caribbean Alliance for Health Disparities Research Group (USCAHDR), Bennett NR, Ferguson TS, Hennis AJM, Wilks RJ, et al. Disparities in cardiovascular disease among Caribbean populations: a systematic literature review. BMC Public Health [Internet]. 2015;15(1). Available from: http://dx.doi.org/10.1186/s12889-015-2166-7
[5] Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: Findings of the national conference on cardiovascular disease prevention. Circulation. 2000;102(25):3137–47.
[6] McGuire TG, Alegria M, Cook BL, Wells KB, Zaslavsky AM. Implementing the Institute of Medicine definition of disparities: an application to mental health care. Health Serv Res. 2006;41(5):1979–2005.
[7] Hackler E III, Lew J, Gore MO, Ayers CR, Atzler D, Khera A, et al. Racial differences in cardiovascular biomarkers in the general population. J Am Heart Assoc [Internet]. 2019;8(18). Available from: http://dx.doi.org/10.1161/jaha.119.012729
[8] Youmans QR, Hastings-Spaine L, Princewill O, Shobayo T, Okwuosa IS. Disparities in cardiovascular care: Past, present, and solutions. Cleve Clin J Med. 2019;86(9):621–32.
[9] Meadows TA, Bhatt DL, Cannon CP, Gersh BJ, Röther J, Goto S, et al. Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Mayo Clin Proc. 2011;86(10):960–7.
[10] Davis AM, Vinci LM, Okwuosa TM, Chase AR, Huang ES. Cardiovascular health disparities. Med Care Res Rev. 2007a;64(5_suppl):29S-100S.
[11] 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology. Journal of Hypertension. 2019;37(2):456.
[12] Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. 2014;100(Suppl 2):ii1-ii67.
[13] Cappuccio F, Cook D, Atkinson R, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart. 1997;78(6):555-563.
[14] Dorans K, Mills K, Liu Y, He J. Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline. Journal of the American Heart Association. 2018;7(11).
[15] George, MG, Schieb, LJ, Ayala, C Pulmonary hypertension surveillance: United States, 2001 to 2010. Chest 2014; 146(2): 476–495.
[16] Kishi, S, Reis, JP, Venkatesh, BA Race-ethnic and sex differences in left ventricular structure and function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. J Am Heart Assoc 2015; 4(3): e001264[17] Yang BQ, Assad TR, O’Leary JM, Xu M, Halliday SJ, D’Amico RW, et al. Racial differences in patients referred for right heart catheterization and risk of pulmonary hypertension. Pulm Circ. 2018;8(2):2045894018764273.
[18] Elliott W. NICE clinical guideline 127: Hypertension: Clinical management of primary hypertension in adults. Yearbook of Cardiology. 2012;2012:1-3.
[19] Campia U, Choucair W, Bryant M, Waclawiw M, Cardillo C, Panza J. Reduced endothelium-dependent and -independent dilation of conductance arteries in African Americans. Journal of the American College of Cardiology. 2002;40(4):754-760.
[20] Gabler N, French B, Strom B, Liu Z, Palevsky H, Taichman D et al. Race and Sex Differences in Response to Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension. Chest. 2012;141(1):20-26.
[21] Myrand S, Sekiguchi K, Man M, Lin X, Tzeng R, Teng C et al. Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian Populations. Clinical Pharmacology & Therapeutics. 2008;84(3):347-361.
[22] Johnson J, Boerwinkle E, Zineh I, Chapman A, Bailey K, Cooper-DeHoff R et al. Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study. American Heart Journal. 2009;157(3):442-449.
[23] Brewster L, van Montfrans G, Oehlers G, Seedat Y. Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity. Internal and Emergency Medicine. 2016;11(3):355-374.
[24] Ritchey M, Chang A, Powers C, Loustalot F, Schieb L, Ketcham M et al. Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries — United States, 2014. MMWR Morbidity and Mortality Weekly Report. 2016;65(36):967-976.
[25] Lauffenburger J, Robinson J, Oramasionwu C, Fang G. Racial/Ethnic and Gender Gaps in the Use of and Adherence to Evidence-Based Preventive Therapies Among Elderly Medicare Part D Beneficiaries After Acute Myocardial Infarction. Circulation. 2014;129(7):754-763.
[26] Zhang Y, Baik S. Race/Ethnicity, Disability, and Medication Adherence Among Medicare Beneficiaries with Heart Failure. Journal of General Internal Medicine. 2013;29(4):602-607.
[27] Liu Q, Quan H, Chen G, Qian H, Khan N. Antihypertensive Medication Adherence and Mortality According to Ethnicity: A Cohort Study. Canadian Journal of Cardiology. 2014;30(8):925-931.
[28] Kandaswamy E, Zuo L. Recent Advances in Treatment of Coronary Artery Disease: Role of Science and Technology. International Journal of Molecular Sciences. 2018;19(2):424.
[29] Zaman M, Philipson P, Chen R, Farag A, Shipley M, Marmot M et al. South Asians and coronary disease: is there discordance between effects on incidence and prognosis?. Heart. 2013;99(10):729-736.
[30] Tillin T, Hughes A, Mayet J, Whincup P, Sattar N, Forouhi N et al. The Relationship Between Metabolic Risk Factors and Incident Cardiovascular Disease in Europeans, South Asians, and African Caribbeans. Journal of the American College of Cardiology. 2013;61(17):1777-1786.
[31] Jose P, Frank A, Kapphahn K, Goldstein B, Eggleston K, Hastings K et al. Cardiovascular Disease Mortality in Asian Americans. Journal of the American College of Cardiology. 2014;64(23):2486-2494.
[32] King K, Khan N, Quan H. Ethnic Variation in Acute Myocardial Infarction Presentation and Access to Care. The American Journal of Cardiology. 2009;103(10):1368-1373.
[33] Zaman M, Crook A, Junghans C, Fitzpatrick N, Feder G, Timmis A et al. Ethnic differences in long-term improvement of angina following revascularization or medical management: a comparison between south Asians and white Europeans. Journal of Public Health. 2008;31(1):168-174.
[34] Iantorno M, Rogers T, Torguson R, Kolm P, Gajanana D, Khalid N et al. Racial Disparities in Clinical Characteristics and Outcomes of Women Undergoing Percutaneous Coronary Intervention. Cardiovascular Revascularization Medicine. 2019;20(12):1039-1042.
[35] Mehta R, Shahian D, Sheng S, O’Brien S, Edwards F, Jacobs J et al. Association of Hospital and Physician Characteristics and Care Processes With Racial Disparities in Procedural Outcomes Among Contemporary Patients Undergoing Coronary Artery Bypass Grafting Surgery. Circulation. 2016;133(2):124-130.
[36] van Ryn M, Burgess D, Malat J, Griffin J. Physicians’ perceptions of patients’ social and behavioural characteristics and race disparities in treatment recommendations for men with coronary artery disease. Am J Public Health . 2006;96(2):351-357.
[37] Mody P, Gupta A, Bikdeli B, Lampropulos J, Dharmarajan K. Most Important Articles on Cardiovascular Disease Among Racial and Ethnic Minorities. Circulation: Cardiovascular Quality and Outcomes. 2012;5(4).
[38] Cavender M, Rassi A, Fonarow G, Cannon C, Peacock W, Laskey W et al. Relationship of Race/Ethnicity With Door-to-Balloon Time and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Findings From Get With the Guidelines-Coronary Artery Disease. Clinical Cardiology. 2013;36(12):749-756.
[39] Albert MA, Ayanian JZ, Silbaugh TS, et al. Early results of Massachusetts healthcare reform on racial, ethnic, and socioeconomic disparities in cardiovascular care. Circulation 2014; 129(24):2528–2538.
[40] Burton B, Munir N, Labastide A, Sanchez R, Gabriel R. An Update on Racial Disparities With 30-Day Outcomes After Coronary Artery Bypass Graft Under the Affordable Care Act. Journal of Cardiothoracic and Vascular Anesthesia. 2019;33(7):1890-1898.
[41] Leigh J, Alvarez M, Rodriguez C. Ethnic Minorities and Coronary Heart Disease: an Update and Future Directions. Current Atherosclerosis Reports. 2016;18(2).
[42] Leigh J, Alvarez M, Rodriguez C. Ethnic Minorities and Coronary Heart Disease: an Update and Future Directions. Current Atherosclerosis Reports. 2016;18(2).
[43] Gijsberts C, Seneviratna A, de Carvalho L, den Ruijter H, Vidanapthirana P, Sorokin V et al. Ethnicity Modifies Associations between Cardiovascular Risk Factors and Disease Severity in Parallel Dutch and Singapore Coronary Cohorts. PLOS ONE. 2015;10(7):e0132278.
[44] Colilla S, Crow A, Petkun W, Singer D, Simon T, Liu X. Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population. The American Journal of Cardiology. 2013;112(8):1142-1147.
[45] Shih T, Ledezma K, McCauley M, Rehman J, Galanter W, Darbar D. Impact of traditional risk factors for the outcomes of atrial fibrillation across race and ethnicity and sex groups. IJC Heart & Vasculature. 2020;28:100538.
[46] Meschia J, Merrill P, Soliman E, Howard V, Barrett K, Zakai N et al. Racial Disparities in Awareness and Treatment of Atrial Fibrillation. Stroke. 2010;41(4):581-587.
[47] Golwala H, Jackson L, Simon D, Fonarow G, Chang P, Gersh B et al. Racial/Ethnic Differences in Atrial Fibrillation Symptoms, Treatment Patterns and Outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation (ORBIT-AF) Registry. Journal of the American College of Cardiology. 2015;65(10):A462.
[48] Mistry A, Vali Z, Sidhu B, Budgeon C, Yuyun M, Pooranachandran V et al. Disparity in implantable cardioverter defibrillator therapy among minority South Asians in the United Kingdom. Heart. 2020;106(9):671-676.
[49] Yuyun M, Squire I, Ng G, Samani N. Evidence for reduced susceptibility to cardiac bradycardias in South Asians compared with Caucasians. Heart. 2018;104(16):1350-1355.
[50] Ugowe F, Jackson L, Thomas K. Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review. Heart Rhythm. 2018;15(9):1337-1345.
[51] Khurshid S, Choi S, Weng L, Wang E, Trinquart L, Benjamin E et al. Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults. Circulation: Arrhythmia and Electrophysiology. 2018;11(7)
[52] Stamos T, Darbar D. The “Double” Paradox of Atrial Fibrillation in Black Individuals. JAMA Cardiology. 2016;1(4):377.
[53] Amponsah M, Benjamin E, Magnani J. Atrial Fibrillation and Race – A Contemporary Review. Current Cardiovascular Risk Reports. 2013;7(5):336-345.
[54] Shen A, Chen W, Yao J, Brar S, Wang X, Go A. Effect of Race/Ethnicity on the Efficacy of Warfarin. CNS Drugs. 2008;22(10):815-825.
[55] Essien U, Holmes D, Jackson L, Fonarow G, Mahaffey K, Reiffel J et al. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation. JAMA Cardiology. 2018;3(12):1174.
[56] Tedla Y, Schwartz S, Silberman P, Greenland P, Passman R. Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients. Journal of Stroke and Cerebrovascular Diseases. 2020;29(5):104718.
[57] Zhang T, Tsang W, Wijeysundera H, Ko D. Reporting and representation of ethnic minorities in cardiovascular trials: A systematic review. American Heart Journal. 2013;166(1):52-57.
[58] Felker G, Mann D. Heart Failure E-Book : A Companion to Braunwald’s Heart Disease. 3rd ed. Philadelphia PA: Elsevier; 2016.
[59] Blackledge H, Newton J, Squire I. Prognosis for South Asian and white patients newly admitted to hospital with heart failure in the United Kingdom: historical cohort study. BMJ. 2003;327(7414):526-531.
[60] Chaturvedi N. Ethnic Differences in Cardiovascular Disease. Heart. 2003;89(6):681-686.[61] Sun L, Kimmoun A, Takagi K, Liu P, Bader Eddeen A, Mebazaa A. Ethnic differences in acute heart failure outcomes in Ontario. International Journal of Cardiology. 2019;291:177-182.
[62] Choi D, Nemi E, Fernando C, Gupta M, Moe G. Differences in the Clinical Characteristics of Ethnic Minority Groups With Heart Failure Managed in Specialized Heart Failure Clinics. JACC: Heart Failure. 2014;2(4):392-399.
[63] Ziaeian B, Heidenreich P, Xu H, DeVore A, Matsouaka R, Hernandez A et al. Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction. JACC: Heart Failure. 2017;5(7):483-493.
[64] Kamath S, Drazner M, Wynne J. Characteristics and Outcomes in African American Patients With Decompensated Heart Failure. Archives of Internal Medicine. 2008;168(11):1152.
[65] Lai E, Grubisic M, Palepu A, Quan H, King K, Khan N. Cardiac medication prescribing and adherence after acute myocardial infarction in Chinese and South Asian Canadian patients. BMC Cardiovascular Disorders. 2011;11(1).
[66] Chong E, Wang H, King-Shier K, Quan H, Rabi D, Khan N. Prescribing patterns and adherence to medication among South-Asian, Chinese and white people with Type 2 diabetes mellitus: a population-based cohort study. Diabetic Medicine. 2014;31(12):1586-1593.
[67] Franciosa J, Ferdinand K, Yancy C. Treatment of Heart Failure in African Americans: A Consensus Statement. Congestive Heart Failure. 2010;16(1):27-38.
[68] Vardeny O, Cavallari L, Claggett B, Desai A, Anand I, Rossignol P et al. Race Influences the Safety and Efficacy of Spironolactone in Severe Heart Failure. Circulation: Heart Failure. 2013;6(5):970-976.
[69] Shekelle PG, Rich MW, Morton SC, Atkinson CS, Tu W, Maglione M, et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol. 2003;41(9):1529–38.
[70] Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2016;37(27):2129-2200.
[71] Sahni S, Horwich T, Fonarow G. Racial and Ethnic Differences in Heart Failure Etiology, Prognosis, and Management. Current Cardiovascular Risk Reports. 2014;9(1).
[72] Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–67. doi: 10.1016/S0022-3999(99)00057-4.
[73] Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343(1):16–22.
[74] Bhatnagar A. Environmental determinants of cardiovascular disease. Circ Res. 2017;121(2):162–80.
[75] Egede LE. Race, ethnicity, culture, and disparities in health care. J Gen Intern Med. 2006;21(6):667–9.
[76] Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, et
al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and
high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob
Health. 2019;7(6):e748–60.
[77] Dhungana RR, Thapa P, Devkota S, Banik PC, Gurung Y, Mumu SJ, et al. Prevalence of cardiovascular disease risk factors: A community-based cross-sectional study in a peri-urban community of Kathmandu, Nepal. Indian Heart J. 2018;70:S20–7.
[78] Eriksen A, Tillin T, O’Connor L, Brage S, Hughes A, Mayet J, et al. The impact of health behaviours on incident cardiovascular disease in Europeans and south Asians – A prospective analysis in the UK SABRE study. PLoS One. 2015;10(3):e0117364.
[79] Brewer LC, Cooper LA. Race, Discrimination, and Cardiovascular Disease. AMA J Ethics. 2014;16(6):455–60.
[80] Hill A, Jones D, Woodworth L. Physician-patient race-match reduces patient mortality [Internet]. 2020 [cited 2020 Aug 23]. Available from: https://papers.ssrn.com/abstract=3211276